Blue Cross Blue Shield of North Carolina and Cambia Health Solutions, the parent of Regence Blues plans in Washington, Oregon, Idaho and Utah, are joining forces to combine corporate and other back-end services under the Cambia name.
The move will draw close national attention because both are members of the Blue Cross Blue Shield group of insurers, which includes 36 companies. Collectively, the Blue insurers are a unique and powerful force in the industry, covering more than 100 million Americans, with deep local market share and a key role in the Affordable Care Act marketplaces. But in recent years the Blue insurers have largely sidestepped industry consolidation that created massive national players, with many remaining independent firms focused on just one state.
Lately, major mergers among Blue insurers “have been once-in-a-blue-moon types of transactions,” said Deep Banerjee, an analyst with S&P Global Ratings. “If there is a transaction, it does open the doors for others to follow….It absolutely can create momentum.”
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Supreme Court Declines to Hear Realtors’ Appeal, DOJ Antitrust Probe Moves Forward
Jan 13, 2025 by
CPI
Commerzbank Chairman Doubts Amicable Merger with UniCredit After Stake Acquisition
Jan 13, 2025 by
CPI
Senator Warren Presses HUD Nominee on Rent Price-Fixing
Jan 13, 2025 by
CPI
Epic Games CEO Accuses Tech Giants of Shifting Loyalties to Court Trump Administration
Jan 13, 2025 by
CPI
Apple’s New Developer Fees Face Renewed Scrutiny from EU Antitrust Regulators
Jan 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand